Telesis Bio Inc. (NASDAQ: TBIO)
$3.51
+0.1500 ( +4.46% ) 32.4K
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents and BioXp biofoundry services.
Market Data
Open
$3.51
Previous close
$3.36
Volume
32.4K
Market cap
$5.91M
Day range
$3.38 - $3.60
52 week range
$3.03 - $29.34
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 16 | Apr 19, 2024 |
4 | Insider transactions | 1 | Apr 19, 2024 |
8-k | 8K-related | 12 | Apr 18, 2024 |
pre | Proxies and info statements | 15 | Apr 09, 2024 |
8-k | 8K-related | 11 | Apr 08, 2024 |
10-k | Annual reports | 122 | Mar 29, 2024 |
8-k | 8K-related | 13 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |